Business

OSL Secures $5.6 million from Major Institutional Investors

OSL Secures $5.6 million from Major Institutional Investors

Oncosil Medical LtdSeptember 7, 20264

OSL Secures $5.6 million from Major Institutional Investors

About this update from Oncosil Medical Ltd

Oncosil Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Oncosil Medical Ltd

More from Oncosil Medical Ltd

OncoSil Receives FDA Approval for Distal Cholangiocarcinoma

August 16, 2026

OncoSil Medical Completes Manufacturing Validation

July 12, 2026

All Oncosil Medical Ltd news →